Celebrating #InternationalMSLDay by recognizing our incredible Medical Science Liaisons, who are experts on our products and act as a resource for the medical community. #ArdelyxProud
Ardelyx, Inc.
生物技术研究
Waltham，MA 18,590 位关注者
Translating Scientific Breakthroughs into Promise for Patients
关于我们
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA? (tenapanor) and XPHOZAH? (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL? (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been submitted in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Community Guidelines: https://rb.gy/07ltg3
- 网站
-
https://www.ardelyx.com
Ardelyx, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Waltham，MA
- 类型
- 上市公司
- 创立
- 2007
地点
Ardelyx, Inc.员工
动态
-
This #NationalKidneyMonth, hear from Ardelyx’s own Alan Ryan, Senior Director, Patient Advocacy, as he shares how the #kidney community inspires him, and how he and others are working tirelessly to improve outcomes for kidney patients. #ArdelyxProud
-
-
We're proud to announce that Ardelyx has been recognized as one of the Top Workplaces! This achievement reflects our commitment to fostering a passionate, inclusive and empowering work environment. Thank you to Team Ardelyx for making this possible! #ArdelyxProud #TopWorkplaces
-
Today, on #WorldKidneyDay, we're proud to recognize Mary Baliker, Erich Ditschman, Nichole Jefferson, Curtis Warfield and David M. White as the first recipients of the Derek Forfang Patient Advocate Award. Learn more: https://bit.ly/3DDrlVD #ArdelyxProud
-
-
Join Dr. Jose Morfin as he presents “A Different Perspective on Hyperphosphatemia Management: Evaluating Current Strategies” at the Annual Dialysis Conference in Las Vegas on March 15. #kidneydisease
-
-
Mark your calendars! Team Ardelyx is on the road this month, attending #GI and #kidneydisease events across the country. See where you can find us!
-
In honor of #NationalKidneyMonth, we want to take a moment to shine a light on all of our incredible advocacy partners. Thank you for all that you do to raise awareness for and improve the lives of individuals and families living with #kidneydisease.
-
Meet Kelli Shaa, Director, Human Resources Operations at Ardelyx. Our culture of care, engagement, and inclusivity fuels our team each and every day. See how you can be a part of Team Ardelyx: https://bit.ly/4dbV9oj #ArdelyxProud
-
-
Today we announced the approval of a New Drug Application by China’s Center for Drug Evaluation of the National Medical Products Administration for tenapanor for hyperphosphatemia. Read the press release here: https://bit.ly/3QASOdj
-
-
Save the date! Today we announced our participation in three upcoming investor conferences: Leerink Partners 2025 Global Healthcare Conference, Jefferies Biotech on the Beach Summit and Barclays 27th Annual Global Healthcare Conference. Learn more: https://bit.ly/3D3LoML